Amplia moves to next stage of cancer drug trial for narmafotinib
Amplia Therapeutics Ltd (ASX:ATX) says that a fourth patient enrolled in a…
Amplia Therapeutics Limited (ASX:ATX)
About Amplia Therapeutics Limited
Key Information
ATX In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 18/11/2024 | Notice of Extraordinary General Meeting/Proxy Form | 552.16KB | 314 |
| 14/11/2024 | Amplia Enters into Preclinical Collaboration | 165KB | 346 |
| 08/11/2024 | Change in substantial holding | 175.98KB | 1.8K |
| 07/11/2024 | Section 708A(5)(e) Notice - Allotment of 67,723,015 Shares | 197.91KB | 258 |
| 06/11/2024 | Substantial Holder Notice - Blueflag Holding Pty Ltd | 107.23KB | 1.9K |
| 06/11/2024 | Application for quotation of securities - ATX | 14.42KB | 257 |
| 05/11/2024 | Proposed issue of securities - ATX | 16.17KB | 315 |
| 01/11/2024 | Update - Proposed issue of securities - ATX | 37.53KB | 245 |